Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia After Intensive Chemotherapy | Aplastic Anemia and MDS International Foundation

Clinical Trial: NCT02226497

Telemonitoring Device in Managing Outpatient Care of Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia After Intensive Chemotherapy
For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov:
Purpose: 

This randomized pilot clinical trial studies a home telemonitoring device in managing the care of patients withmyelodysplastic syndrome or acute myeloid leukemia after they are discharged from the hospital following chemotherapy. After treatment and hospital discharge, patients typically need extensive care to deal with the side effects of chemotherapy, keep up with medications, and obtain medical assistance. A home telemonitoring device would allow patients to monitor vital signs, symptoms, and use of medications, communicate with healthcare providers, and access educational material. A telemonitoring device may allow patients to be managed more effectively than standard outpatient care after being discharged from the hospital.

Status: 
Recruiting
Study Date: 
Thu, 01/01/2015 to Thu, 09/01/2016
Bone Marrow Disease(s): 
myelodysplastic syndromes (MDS)
Intervention: 
Device: Health Telemonitoring Use home telemonitoring device Other: Quality-of-Life Assessment Ancillary studies Other Name: Quality of Life Assessment Other: Questionnaire Administration Ancillary studies Procedure: Supportive Care Receive standard outpatient supportive care Other Names: Supportive Therapy Symptom Management Therapy, Supportive